Literature DB >> 29190176

Correlation of serum ferritin levels with hepatic MRI T2 and liver iron concentration in nontransfusion beta-thalassemia intermediate patients: A contemporary issue.

Mehran Karimi1, Fatemeh Amirmoezi1, Sezaneh Haghpanah1, Seyedpouria Ostad2, Mehrzad Lotfi3, Sepideh Sefidbakht3, Shahed Rezaian2.   

Abstract

BACKGROUND: Beta-thalassemia intermediate is a genetic disease that is milder than beta-thalassemia major. The T2* magnetic resonance imaging (MRI) technique is currently the gold standard for iron load detection. However, it is expensive and needs an expert radiologist to report findings. Therefore, we conducted this study to determine an optimal cut-off value of ferritin in proportion to T2 MRI of liver and measurement of liver iron concentration for early detection of hepatic iron overload in Beta-thalassemia intermediate patients.
METHODS: This cross-sectional study was conducted on 108 patients with Beta-thalassemia intermediate who referred to tertiary hospital, Shiraz, Iran. Serum ferritin, hepatic T2 MRI, and liver iron concentration were assessed. Receiver operator characteristic was used to determine the sensitivity and specificity of cut-off value.
RESULTS: Serum ferritin levels showed a statistically significant negative correlation with T2 hepatic MRI (r = -0.290, p value =.003) and positive correlation with liver iron concentration (r = 0.426, p value <.001) in the patients with Beta-thalassemia intermediate. According to the receiver operator characteristic, the best cut-off value for ferritin to show early diagnosis of liver iron overload was 412 ng/mL. Calculated sensitivities and specificities were 0.78 and 0.82 for T2 MRI and 0.76 and 0.86 for liver iron concentration, respectively.
CONCLUSION: Serum ferritin levels of around 450 ng/mL might be considered as a cut-off point to evaluate hepatic iron overload before using expensive, not readily available T2 MRI. This level of serum ferritin could be considered for starting iron chelation therapy in patients with Beta-thalassemia intermediate in areas where T2 MRI is not available.

Entities:  

Keywords:  Beta-thalassemia intermediate; liver iron concentration; serum ferritin

Mesh:

Substances:

Year:  2017        PMID: 29190176     DOI: 10.1080/08880018.2017.1400135

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  4 in total

1.  Impact of Genotype of Beta Globin Gene on Hepatic and Myocardial Iron Content in Egyptian Patients with Beta Thalassemia.

Authors:  Tamer H Hassan; Mohamed M Abdel Salam; Marwa Zakaria; Mohamed Shehab; Dina T Sarhan; El Sayed H Zidan; Khaled M El Gerby
Journal:  Indian J Hematol Blood Transfus       Date:  2018-11-08       Impact factor: 0.900

2.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

3.  Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry.

Authors:  Hishamshah Mohd Ibrahim; Zulaiha Muda; Ida Shahnaz Othman; Mohamed Najib Mohamed Unni; Kok Hoi Teh; Asohan Thevarajah; Kogilavani Gunasagaran; Gek Bee Ong; Seoh Leng Yeoh; Aisyah Muhammad Rivai; Che Hadibiah Che Mohd Razali; Nazzlin Dizana Din; Zarina Abdul Latiff; Rahman Jamal; Norsarwany Mohamad; Hany Mohd Ariffin; Hamidah Alias
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

4.  Correlation of Liver and Myocardium Iron Concentration Determined by Magnetic Resonance Imaging With Serum Ferritin in Non-Transfusion-Dependent Thalassemia Patients.

Authors:  Nagenthran Gayathri; M Vasantha Kumar; Thangam Vinoth; Radhan Prabhu; S Krishnabharath
Journal:  Cureus       Date:  2022-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.